Hypersensitivity to IV Ustekinumab but Tolerance to Subcutaneous Ustekinumab in a Patient With Crohn's Disease

por Krugliak Cleveland, Noa, Masching, Alexandra, Rubin, David T.
Publicado 2020

Combining Cyclosporine With Ustekinumab in Acute Severe Ulcerative Colitis

por Shaffer, Seth R., Traboulsi, Cindy, Krugliak Cleveland, Noa, Rubin, David T.
Publicado 2021

Evolving role of endoscopy in inflammatory bowel disease: Going beyond diagnosis

por Núñez F, Paulina, Krugliak Cleveland, Noa, Quera, Rodrigo, Rubin, David T
Publicado 2021

Rapid Onset of Inflammatory Bowel Disease after Receiving Secukinumab Infusion

por Wang, Jingzhou, Bhatia, Arvin, Krugliak Cleveland, Noa, Gupta, Nina, Dalal, Sushila, Rubin, David T., Sakuraba, Atsushi
Publicado 2018

Real-World Effectiveness and Safety of Ustekinumab for Ulcerative Colitis From 2 Tertiary IBD Centers in the United States

por Hong, Simon J, Krugliak Cleveland, Noa, Akiyama, Shintaro, Zullow, Samantha, Yi, Yangtian, Shaffer, Seth R, Malter, Lisa B, Axelrad, Jordan E, Chang, Shannon, Hudesman, David P, Rubin, David T
Publicado 2021

Inflammation in the proximal colon is a risk factor for the development of colorectal neoplasia in inflammatory bowel disease patients with primary sclerosing cholangitis

por Jamil, Omar K., Shaw, Dustin, Deng, Zifeng, Dinardi, Nicholas, Fillman, Natalie, Khanna, Shivani, Krugliak Cleveland, Noa, Sakuraba, Atsushi, Weber, Christopher R., Cohen, Russell D., Dalal, Sushila, Jabri, Bana, Rubin, David T., Pekow, Joel
Publicado 2023